BiotechTube
Home/Juvenescence/Gill Dines
GD

Gill Dines

Chief Scientific Officer (CSO)

Juvenescence

Therapeutic Areas

AgingAge-related Diseases

Juvenescence Pipeline

DrugIndicationPhase
PAI-1 InhibitorAging / Age-related ConditionsPhase 1

Leadership Team at Juvenescence

DG
Dr. Greg Bailey
Co-founder
JM
Jim Mellon
Co-founder/Investor
EJ
Eileen Jennings-Brown
Chief Technology Officer (CTO)
View full Juvenescence profile